Oligonucleotide Synthesis Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Oligonucleotide Synthesis Market to 2027 - Global Analysis and Forecasts By Product (Synthesized Oligonucleotides, Reagents, and Equipment), Application (Research, Diagnostics, and Therapeutics), End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Other End Users), and Geography

Report Code: TIPBT00002549 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Oligonucleotides are short fragments of nucleic acids that are synthesized using genetic engineering and enzyme chemistry. These are mostly used in laboratories in applications such as therapeutic, diagnostics as well as academic and industrial. These are used from initial research and screening through to target validation and drug production. Today, subsequent improvements in oligonucleotide synthesis, amplification and automation has completely revolutionized biological research. It is also possible to do the customizations and get the required sequence online easily and at the required time.

The market of oligonucleotide synthesis is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing research and development activities, and rising demand for new drug development for rare and genetic disease is expected to drive growth of biotechnology. Furthermore, rising prevalence of cancer and infectious diseases, and advancements in oligonucleotide synthesis technologies are expected to spur the demand for oligonucleotide synthesis. However, growing focus on personalized medicine is expected to offer growth opportunities for the players operating in the oligonucleotide synthesis market.

The "Global Oligonucleotide Synthesis Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global oligonucleotide synthesis market with detailed market segmentation by product, application, end-user, and geography. The global oligonucleotide synthesis market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the oligonucleotide synthesis market.

The global oligonucleotide synthesis market is segmented on the basis of product, application, and end-user. The product segment includes, synthesized oligonucleotides, reagents, and equipment. The segment of synthesized oligonucleotides is further classified into, primers, probes, large-scale synthesis oligonucleotides, and others synthesized oligonucleotides. On the application basis oligonucleotide synthesis market is segmented as, research, diagnostics, and therapeutics software. Based on end user, the oligonucleotide synthesis market is classified as, academic research institutes, pharmaceutical & biotechnology companies, diagnostic laboratories, and other end users.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global oligonucleotide synthesis market based on product, application, and end-user. It also provides market size and forecast till 2027 for overall oligonucleotide synthesis market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The oligonucleotide synthesis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to account for the largest share of the oligonucleotide synthesis market, with the majority of growth primarily driven by well-developed and established healthcare industry, and growing number of pharmaceutical companies leveraging oligonucleotides in therapeutics, research and diagnostics are factors driving the market in North America. However, Asia Pacific region is expected to be the fastest growing region of the global oligonucleotide synthesis market during forecast period. This can be attributed to factors such as the growing availability of synthesized oligos, rise in venture capital investments, and along with an increase in R&D funding and activities in the APAC region these are the primary factor which is driving the growth of oligonucleotide synthesis market.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key oligonucleotide synthesis manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Agilent Technologies, Merck KGaA, Darmstadt, Germany, Maravai LifeSciences, Thermo Fisher Scientific Inc., General Electric Company, TriLink BioTechnologies, LLC, LGC Limited, Danaher, Eurogentec, and BioAutomation among other.
Table of Contents

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. OLIGONUCLEOTIDE SYNTHESIS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Oligonucleotide Synthesis Market - By Product
3.2.2. Oligonucleotide Synthesis Market - By Application
3.2.3. Oligonucleotide Synthesis Market - By End User
3.2.4. Oligonucleotide Synthesis Market - By Region
3.2.4.1. By Country
4. OLIGONUCLEOTIDE SYNTHESIS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. OLIGONUCLEOTIDE SYNTHESIS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET OVERVIEW
5.2. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS
?
6. OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - BY PRODUCT
6.1. OVERVIEW
6.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. SYNTHESIZED OLIGONUCLEOTIDES MARKET
6.3.1. Overview
6.3.2. Synthesized Oligonucleotides Market Revenue Forecasts and Analysis (US$ Mn)
6.3.3. Primers Market
6.3.3.1. Overview
6.3.3.2. Primers Filters Market Revenue Forecasts and Analysis (US$ Mn)
6.3.4. Probes Market
6.3.4.1. Overview
6.3.4.2. Probes Market Revenue Forecasts and Analysis (US$ Mn)
6.3.5. Large-Scale Synthesis Oligonucleotides Market
6.3.5.1. Overview
6.3.5.2. Large-Scale Synthesis Oligonucleotides Market Revenue Forecasts and Analysis (US$ Mn)
6.3.6. Others Market
6.3.6.1. Overview
6.3.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
6.4. REAGENTS MARKET
6.4.1. Overview
6.4.2. Reagents Market Revenue Forecasts and Analysis (US$ Mn)
6.5. EQUIPMENT MARKET
6.5.1. Overview
6.5.2. Equipment Market Revenue Forecasts and Analysis (US$ Mn)

?
7. OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - BY APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. RESEARCH MARKET
7.3.1. Overview
7.3.2. Research Market Revenue Forecasts and Analysis (US$ Mn)
7.4. DIAGNOSTICS MARKET
7.4.1. Overview
7.4.2. Diagnostics Market Revenue Forecasts and Analysis (US$ Mn)
7.5. THERAPEUTICS MARKET
7.5.1. Overview
7.5.2. Therapeutics Market Revenue Forecasts and Analysis (US$ Mn)

8. OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. ACADEMIC RESEARCH INSTITUTES MARKET
8.3.1. Overview
8.3.2. Academic Research Institutes Market Revenue Forecasts and Analysis (US$ Mn)
8.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET
8.4.1. Overview
8.4.2. Pharmaceutical & Biotechnology Companies Market Revenue Forecasts and Analysis (US$ Mn)
8.5. DIAGNOSTIC LABORATORIES MARKET
8.5.1. Overview
8.5.2. Diagnostic Laboratories Market Revenue Forecasts and Analysis (US$ Mn)
8.6. OTHER END USERS MARKET
8.6.1. Overview
8.6.2. Other End Users Market Revenue Forecasts and Analysis (US$ Mn)

9. NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET OVERVIEW
9.2. NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
9.3.1. North America Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.4. NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET VOLUME AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
9.5. NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET VOLUME AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.6. NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.7. US MARKET OVERVIEW
9.7.1. US Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.7.1.1. US Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.7.2. US Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7.3. US Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. CANADA MARKET OVERVIEW
9.8.1. Canada Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.8.1.1. Canada Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.8.2. Canada Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.9. MEXICO MARKET OVERVIEW
9.9.1. Mexico Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.9.1.1. Mexico Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.9.2. Mexico Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)

?
10. EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET OVERVIEW
10.2. EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
10.3.1. Europe Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.4. EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.5. EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET VOLUME AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.6. EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.7. UK MARKET OVERVIEW
10.7.1. UK Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.7.1.1. UK Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.7.2. UK Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7.3. UK Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. GERMANY MARKET OVERVIEW
10.8.1. Germany Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.8.1.1. Germany Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.8.2. Germany Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8.3. Germany Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. FRANCE MARKET OVERVIEW
10.9.1. France Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.9.1.1. France Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.9.2. France Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.9.3. France Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)

11. ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET OVERVIEW
11.2. ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
11.3.1. Asia Pacific Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.4. ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.5. ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET VOLUME AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.6. ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.7. JAPAN MARKET OVERVIEW
11.7.1. Japan Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.7.1.1. Japan Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.7.2. Japan Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7.3. Japan Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. CHINA MARKET OVERVIEW
11.8.1. China Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.8.1.1. China Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.8.2. China Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8.3. China Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)
?
11.9. INDIA MARKET OVERVIEW
11.9.1. India Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.9.1.1. India Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.9.2. India Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.9.3. India Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)

12. MIDDLE EAST AND AFRICA (MEA) OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA (MEA) OLIGONUCLEOTIDE SYNTHESIS MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA (MEA) OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA (MEA) OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
12.3.1. Middle East and Africa (MEA)Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.4. MIDDLE EAST AND AFRICA (MEA)OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.5. MIDDLE EAST AND AFRICA (MEA)OLIGONUCLEOTIDE SYNTHESIS MARKET VOLUME AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.6. MIDDLE EAST AND AFRICA (MEA)OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.7. SOUTH AFRICA MARKET OVERVIEW
12.7.1. South Africa Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.7.1.1. South Africa Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.7.2. South Africa Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.7.3. South Africa Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)
?
12.8. SAUDI ARABIA MARKET OVERVIEW
12.8.1. Saudi Arabia Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.8.1.1. Saudi Arabia Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.8.2. Saudi Arabia Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.8.3. Saudi Arabia Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.9. UAE MARKET OVERVIEW
12.9.1. UAE Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.9.1.1. UAE Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.9.2. UAE Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.9.3. UAE Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)

13. SOUTH AND CENTRAL AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
13.3.1. South and Central America Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
13.4. SOUTH AND CENTRAL AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET VOLUME AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.6. SOUTH AND CENTRAL AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
?
13.7. BRAZIL MARKET OVERVIEW
13.7.1. Brazil Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.7.1.1. Brazil Synthesized Oligonucleotides Market Revenue and Forecasts Analysis - By Type (US$ MN)
13.7.2. Brazil Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.7.3. Brazil Oligonucleotide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)

14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions
15. OLIGONUCLEOTIDE SYNTHESIS MARKET, KEY COMPANY PROFILES
15.1. AGILENT TECHNOLOGIES
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. MERCK KGAA
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. MARAVAI LIFESCIENCES
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. THERMO FISHER SCIENTIFIC INC.
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. GENERAL ELECTRIC
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. TRILINK BIOTECHNOLOGIES, LLC
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Financial Overview
15.6.4. Product Portfolio
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. LGC LIMITED
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. DANAHER
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. EUROGENTEC
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. BIOAUTOMATION
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. SWOT Analysis
15.10.6. Key Developments

16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
The List of Companies

1. Agilent Technologies
2. Merck KGaA
3. Maravai LifeSciences
4. Thermo Fisher Scientific Inc.
5. General Electric Company
6. TriLink BioTechnologies, LLC
7. LGC Limited
8. Danaher.
9. Eurogentec
10. BioAutomation

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book